SYNALAR C SYNALAR C CLIOQUINOL HYDROCORTISONE CLIOQUINOL HYDROCORTISONE CLIOQUINOL PROVATE-C PROVAT-C PROVAT-C

Dose: 3%
Single Dose: 3 (3)
Frequency: 12 hourly
Route: Topical
Instructions: For not more than 7 days

Dose: 3%
Single Dose: 3 (3)
Frequency: 12 hourly
Route: Topical
Instructions: For not more than 7 days

Dose: 3%
Single Dose: 3 (3)
Frequency: 12 hourly
Route: Topical
Instructions: For not more than 7 days

Iodochllerohy droxygen is the derivative of Clioquinol. It is of Synthetic origin and belongs to Idoquinoline. It belongs to Dermatological Products and Antifungal Agent, Topical pharmacological group.The Molecular Weight of Clioquinol is 305.50.

Clioquinol is contraindicated in conditions like Nail fungal infection,Infection of scalp.

The severe or irreversible adverse effects of Clioquinol, which give rise to further complications include Peripheral neuropathy, Optic neuropathy.Clioquinol produces potentially life-threatening effects which include severe neurotoxicity. which are responsible for the discontinuation of Clioquinol therapy.

Clioquinol is primarily indicated in conditions like Fungal infection, Ringworm, Skin infections, Tinea cruris, Tinea pedis, and can also be given in adjunctive therapy as an alternative drug of choice in Otitis externa.

No data regarding the interactions of Clioquinol was found.

Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Cream Store in a well closed container, Below 40°C. Do not Freeze. Protect from Sunlight and Moisture.

Clioquinol should be used with caution in patients with iodine iontolerence, medical history or any allergy. May irritate sensitized skin; topical application possess a potential risk of toxicity to infants and children. It is classified as pregnancy category C and should be used with caution during pregnancy only if clearly needed.